Member Info for init2oneit

Co website still shows Hudson and Tarassenko as Directors although they were gone In June. So even there some detail needs updating.

It says this was posted 11 days ago.

https://uk.indeed.com/viewjob?jk=96310aaa6d161d9f

Group accounts should be published this month. As a PLC, I think they were RNS’d early Oct last year and available on the Companies House website, early Nov.

Also hold a significant amount here.

Previous accounts too have been re-submitted with Richard Pye’s signature as CFO, removing Drayson’s
Drayson’s signature. So Richard Pye has signed off old accounts.

Looks like they are making a clean start with corporate governance too.

This was this time last year. A lot has happened since with the Co though and whether collaboration with Bayer in Lifehub is still ongoing.

https://www.bayer.co.uk/en/lifehubuk-birthday

They seem to have made progress on separating the Co into parts. Looks like they have replaced PwC with Grant Thornton. All the big pharma cos, Bayer GSK etc have recently pledged more investment into AI. It’s whether a sale could still be considered if anyone is still interested or if the loan note holders want an ‘out’ with a realist in the US, sometime in the future. Also how long Alex Snow is willing to further develop the Co.

The division Sensyne Health Holdings made a profit of £22.7 m with net assets of £82m year ended Apr21. Grant Thornton audit signed off in Aug. All available at Companies House website.

As of 1st Aug 22 £6.5 m cash balance and £8 m still available to be drawn loan ( loan notes) at discretion of holders.

Divestments “ Complex clinical and regulatory pathway these products must operate in “ are having an impact on timing and completion

Agreement with OUHF Trust to our license SEND
Operations in magnifeye closed jul 22 although Technology available for acquisition.

A very comprehensive auditors report signed off by Grant Thornton just 4 weeks ago. Phesi collaboration seen as a 7 year benefit. ‘Going concern’ still very much in the hands of loan note holders. No divestment completed as of 26 Aug. It’s worth a read through and looks quite a ‘due diligence’ auditors and directors report warts and all.

That is For Sensyne Health Group Ltd, made up until April 2021.

Sorry not sure that link works but available on Companies House website.

Are here

https://s3.eu-west-2.amazonaws.com/document-api-images-live.ch.gov.uk/docs/tmByB5fXhZhQC6CfR6_n0ZPz8PGqZyVKxIsLUkNZ6pA/application-pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAWRGBDBV3EI6UFW5A%2F20220923%2Feu-west-2%2Fs3%2Faws4_request&X-Amz-Date=20220923T115345Z&X-Amz-Expires=60&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEPr%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCWV1LXdlc3QtMiJHMEUCIQDlLoyZtAHWEfDSWZECXnUAqmhxYVpOXjfSPuBUCPefCwIgTCCevuy1KZ01sDpLeqlTJIhfdCG7Dnx7bLafPTHBiZ8q1gQIo%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARAEGgw0NDkyMjkwMzI4MjIiDPd0vvS49OMkNUFuJSqqBEl4%2BpDoZnTU4UQ1iniDZFn9N3tG5AXAjiiWURh2UxJWmD57drudbNK3a6rB4Azhj6qK0tfgv03mRj9VgxwJtBmEtT4t6Om2V6YamPVNPorQQcb8F26MujFRmdJU7f9DpHIVtAfXysYwmLsmyTe%2BuuQx8J6EQOX9N24egRDknXm5F38NRpvyC8RkAPvoDLBT4tTf2kLVcgG7Zh21CKmcqApEnBRhwTptSIidFVwyC4g0lNeSI6tRJrnbAJLoUU2PCm7CNeEAoai8UFpo0tvCnBRM91BjtS%2BsjYU4ZNyDhfO27BW%2BmoJo%2B8%2F%2FYTLi%2BQBPF%2F98Up%2FgyayD%2F5LcFBLw6oixVG7sBHKNM%2FIqkqEUhd59PDBFCaEV5g9xCEDdXI%2FJlewIOe%2Bi9%2BcvRrD%2BiPNk%2FP%2BwDzTfxy0cQYMkHFNNzHA27zw1OzS53BMsBHkgARHIyISMcTPgsTIDI5yiIpI5548vzvMXfjRJOrqqfUXGu0oVeg3KeRLKyjzoeyR4p2%2FT6meVmcx6TUhElpxZBFpmDBkbvaWrFxkiy7JFhPWQqxcQVCVY4zO%2F42vmPodbuXkva7qSLlYxNdW1%2FmZA3MTHfK4Hu7NnzGr7ylOjkG0MqKk%2Bwlj2zk8kNI4DCuE%2BWowygpnM3jcT0lHFTW8zI2D6uLZpgcGZ7ISstRo3LjdW3vmDHkW%2FUdUjLttKDnotEHo6f0ceLhqwmzf8C4AblA1FGDiBHHP2dC1SAPahMJ%2F3tZkGOqkBjjoyzoH22KCsXe4wcl9Eru%2FaPF%2FLaQENp8L4eNv8GEwm9b1yNWme2A557orB9EEze49W6Qs833DNnU4Tan6AKvmYJOgTvZJyIOtqfYq0X%2FjJG0F6RC2c%2FhU97sxlSnOUhfiza5%2F5fit8LmyOg7i1C0AdOrOcb%2FL5IgpMO%2BrARgBorj0he4LJsIZx8knM4jiNqnkLWb%2F23wVzFuZaVbLf18F3Lydxx91fgg%3D%3D&X-Amz-SignedHeaders=host&response-content-disposition=inline%3Bfilename%3D%22companies_house_document.pdf%22&X-Amz-Signature=2e4dfe5c29056d565970901b6d33abd5c2703418135d73b09cadc83e2fea6826

£ or $, depends what report you read but the collaboration is valid for 5 years.

It was a £10 million equity investment in Phesi. ( not $ )

https://www.phesi.com/news/sensyne-grows-medical-research-dataset-to-60-million-patients/

One wonders what , if anything, has been happening with this collaboration and what Sen’s investment in Phesi is worth.

https://www.sensynehealth.com/newsroom/sensyne-health-and-phesi-enter-joint-commercial-development-collaboration-with-a-leading-pharmaceutical-company

Just as a reminder … 10 million dollars invested by Sens into Phesi

https://www.phesi.com/news/phesi-and-sensyne-health-agree-collaboration-to-advance-development-of-synthetic-arms-in-clinical-trials/

https://www.phesi.com/news/analysis-of-alzheimers-patients/

Wonder why Bayer parted with Exscientia.

Not a whiff anywhere yet of any divestments by Sensyne and I believe it was around the end of 2019 that Bayer signed a 2 year deal with Sensyne.

https://aibusiness.com/document.asp?doc_id=779027

https://www.fiercebiotech.com/biotech/bayer-parts-ways-exscientia-leaving-one-target-ai-drug-hunters-hands